The company is targeting three major cost drivers: cell line development, growth media and bioprocessing, as food technology businesses seek commercially viable ways to scale alternative protein production.
The new Wisconsin facility is Kikkoman Foods’ third US production site and is designed to strengthen supply capacity while supporting advanced food manufacturing and sustainability goals.
The strategic funding comes as Above Food advances its restructuring, Nasdaq relisting efforts and commercialization plans.
The expanded partnership strengthens access to vitamins, cultures, enzymes and nutritional ingredients for food and beverage manufacturers across Southeast Asia.
The ingredients manufacturer reported strong growth in fragrances and food ingredients while confirming plans to cut around 1,000 jobs worldwide.